Powder dispensing technology offers innovation for pharmaceutical industry

GiroNEX has announced details of a precision powder dispensing technology that could significantly increase the pharmaceutical industry’s ability to offer patient-specific dosing.

The technology created can quickly dispense powders - image courtesy of GiroNEX.
The technology created can quickly dispense powders – image courtesy of GiroNEX.

The new Cambridgeshire-based technology company could offer more effective treatments for specific conditions.

The technology created can quickly dispense from 0.1 milligrams to five grams of pharmaceutical or other chemical powders into vials or capsules, with accuracy of 2% or better.

This innovative approach has been developed to target opportunities in strictly regulated production environments.

GiroNEX could also help enable a new generation of automated ‘dispense and weigh’ systems for use in pharmaceutical R&D and other laboratory-based applications.

The technology

The company uses a gently oscillating powder dispensing mechanism that is reportedly capable of dispensing even the most sensitive of powders without damaging them.

By using a series of interchangeable dispensing heads that covers a typical mass range and provides limitless dispensing capability, the technology is cost effective and easier to use than current existing technologies, according to the company.

The technology created can quickly dispense powders - image courtesy of GiroNEX.
The company has based its technology on a proprietary algorithm that learns how best to dispense new powders – image courtesy of GiroNEX.

The team has based its technology on an innovative and proprietary algorithm that learns how best to dispense new powders – effectively characterising a powder’s flow behaviour while it is being dispensed.

As a result, users could no longer need to invest valuable R&D time and resources in developing and testing reliable powder dispensing methods.

The company expects to take its first laboratory system into production at the beginning of 2019.

Digitalising the pharmaceutical industry

A report released earlier this year by Santander and EEF, highlighted the five primary growth opportunities for UK pharmaceutical businesses.

  • Personalised medicine
  • Technology
  • Accelerated Access Pathway
  • Ageing population
  • Demand from emerging markets

Read the full article here.